Sfoglia per Rivista
Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C
2006-01-01 Borroni, G.; Ceriani, R.; Cazzaniga, M.; Tommasini, M.; Roncalli, M.; Maltempo, C.; Felline, C.; Salerno, F.
Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group.
1999-01-01 Annese, V; Bassotti, G; Coccia, G; D'Onofrio, V; Gatto, G; Repici, A; Andriulli, A.
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients
2019-01-01 Pouillon, L; Danese, S; Hart, A; Fiorino, G; Argollo, M; Selmi, C; Carlo Stella, C; Loeuille, D; Costanzo, A; Lopez, A; Vegni, E; Radice, S; Gilardi, D; Socha, M; Fazio, M; Gonzalez-Lorenzo, M; Bonovas, S; Magro, F; Peyrin-Biroulet, L
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply
2018-01-01 Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S
Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non‐elderly patients with inflammatory bowel disease—the IG‐IBD LIVE study. Authors' reply
2022-01-01 Pugliese, Daniela; Privitera, Giuseppe; Armuzzi, Alessandro
Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply
2017-01-01 Bonovas, S; Fiorino, G; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease
2014-01-01 Cesarini, M; Danese, S
Editorial: should we abandon HCV genotype testing? Maybe
2019-01-01 Torres, Mcp; Aghemo, A
Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis—a step towards precision medicine?
2022-01-01 Solitano, Virginia; Armuzzi, Alessandro
Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply
2018-01-01 Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling?
2021-01-01 Pugliese, D; Armuzzi, A
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study
2022-01-01 Pugliese, Daniela; Privitera, Giuseppe; Crispino, Federica; Mezzina, Nicolò; Castiglione, Fabiana; Fiorino, Gionata; Laterza, Lucrezia; Viola, Anna; Bertani, Lorenzo; Caprioli, Flavio; Cappello, Maria; Barberio, Brigida; Ricci, Chiara; Balestrieri, Paola; Daperno, Marco; Pluchino, Dario; Rizzello, Fernando; Scribano, Maria Lia; Sablich, Renato; Pastorelli, Luca; Manguso, Francesco; Variola, Angela; Di Sario, Antonio; Grossi, Laurino; Armuzzi, Alessandro; Null, Null
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
2020-01-01 Sands, Be; Armuzzi, A; Marshall, Jk; Lindsay, Jo; Sandborn, Wj; Danese, S; Panes, J; Bressler, B; Colombel, Jf; Lawendy, N; Maller, E; Zhang, Hy; Chan, G; Salese, L; Tsilkos, K; Marren, A; Su, Cy
Efficacy of a multistep strategy for Helicobacter pylori eradication
2000-01-01 Gasbarrini, A; Ojetti, V; Armuzzi, A; Branca, G; Canducci, F; Torre, Es; Candelli, M; Pastorelli, A; Anti, M; Fedeli, G; Fadda, G; Pola, P; Gasbarrini, G
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
2006-01-01 Zocco, Ma; Dal Verme, Lz; Cremonini, F; Piscaglia, Ac; Nista, Ec; Candelli, M; Novi, M; Rigante, D; Cazzato, Ia; Ojetti, V; Armuzzi, A; Gasbarrini, G; Gasbarrini, A
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection
2000-01-01 Cammarota, G; Cianci, R; Cannizzaro, O; Cuoco, L; Pirozzi, G; Gasbarrini, A; Armuzzi, A; Zocco, Ma; Santarelli, L; Arancio, F; Gasbarrini, G
Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case-control study
2005-01-01 Morini, S; Hassan, Cesare; Zullo, A; De Francesco, V; Burattini, O; Margiotta, M; Panella, C; Ierardi, E.
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection
2000-01-01 Cammarota, G; Cannizzaro, O; Ojetti, V; Cianci, R; Pastorelli, A; Armuzzi, A; Gentiloni, N; Gasbarrini, A; Pirozzi, G; Gasbarrini, G
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply
2010-01-01 Szabo, H; Fiorino, G; Danese, S
Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy
1999-01-01 Rinaldi, V; Zullo, A; De Francesco, V; Hassan, Cesare; Winn, S; Stoppino, V; Faleo, D; Attili, Af
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C | 1-gen-2006 | Borroni, G.; Ceriani, R.; Cazzaniga, M.; Tommasini, M.; Roncalli, M.; Maltempo, C.; Felline, C.; Salerno, F. | |
Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group. | 1-gen-1999 | Annese, V; Bassotti, G; Coccia, G; D'Onofrio, V; Gatto, G; Repici, A; Andriulli, A. | |
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients | 1-gen-2019 | Pouillon, L; Danese, S; Hart, A; Fiorino, G; Argollo, M; Selmi, C; Carlo Stella, C; Loeuille, D; Costanzo, A; Lopez, A; Vegni, E; Radice, S; Gilardi, D; Socha, M; Fazio, M; Gonzalez-Lorenzo, M; Bonovas, S; Magro, F; Peyrin-Biroulet, L | |
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply | 1-gen-2018 | Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S | |
Editorial: effectiveness and safety of vedolizumab in a matched cohort of elderly and non‐elderly patients with inflammatory bowel disease—the IG‐IBD LIVE study. Authors' reply | 1-gen-2022 | Pugliese, Daniela; Privitera, Giuseppe; Armuzzi, Alessandro | |
Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply | 1-gen-2017 | Bonovas, S; Fiorino, G; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S | |
Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease | 1-gen-2014 | Cesarini, M; Danese, S | |
Editorial: should we abandon HCV genotype testing? Maybe | 1-gen-2019 | Torres, Mcp; Aghemo, A | |
Editorial: STAT3 phosphorylation for tofacitinib monitoring in ulcerative colitis—a step towards precision medicine? | 1-gen-2022 | Solitano, Virginia; Armuzzi, Alessandro | |
Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply | 1-gen-2018 | Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S | |
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling? | 1-gen-2021 | Pugliese, D; Armuzzi, A | |
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study | 1-gen-2022 | Pugliese, Daniela; Privitera, Giuseppe; Crispino, Federica; Mezzina, Nicolò; Castiglione, Fabiana; Fiorino, Gionata; Laterza, Lucrezia; Viola, Anna; Bertani, Lorenzo; Caprioli, Flavio; Cappello, Maria; Barberio, Brigida; Ricci, Chiara; Balestrieri, Paola; Daperno, Marco; Pluchino, Dario; Rizzello, Fernando; Scribano, Maria Lia; Sablich, Renato; Pastorelli, Luca; Manguso, Francesco; Variola, Angela; Di Sario, Antonio; Grossi, Laurino; Armuzzi, Alessandro; Null, Null | |
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open | 1-gen-2020 | Sands, Be; Armuzzi, A; Marshall, Jk; Lindsay, Jo; Sandborn, Wj; Danese, S; Panes, J; Bressler, B; Colombel, Jf; Lawendy, N; Maller, E; Zhang, Hy; Chan, G; Salese, L; Tsilkos, K; Marren, A; Su, Cy | |
Efficacy of a multistep strategy for Helicobacter pylori eradication | 1-gen-2000 | Gasbarrini, A; Ojetti, V; Armuzzi, A; Branca, G; Canducci, F; Torre, Es; Candelli, M; Pastorelli, A; Anti, M; Fedeli, G; Fadda, G; Pola, P; Gasbarrini, G | |
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis | 1-gen-2006 | Zocco, Ma; Dal Verme, Lz; Cremonini, F; Piscaglia, Ac; Nista, Ec; Candelli, M; Novi, M; Rigante, D; Cazzato, Ia; Ojetti, V; Armuzzi, A; Gasbarrini, G; Gasbarrini, A | |
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection | 1-gen-2000 | Cammarota, G; Cianci, R; Cannizzaro, O; Cuoco, L; Pirozzi, G; Gasbarrini, A; Armuzzi, A; Zocco, Ma; Santarelli, L; Arancio, F; Gasbarrini, G | |
Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case-control study | 1-gen-2005 | Morini, S; Hassan, Cesare; Zullo, A; De Francesco, V; Burattini, O; Margiotta, M; Panella, C; Ierardi, E. | |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection | 1-gen-2000 | Cammarota, G; Cannizzaro, O; Ojetti, V; Cianci, R; Pastorelli, A; Armuzzi, A; Gentiloni, N; Gasbarrini, A; Pirozzi, G; Gasbarrini, G | |
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply | 1-gen-2010 | Szabo, H; Fiorino, G; Danese, S | |
Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy | 1-gen-1999 | Rinaldi, V; Zullo, A; De Francesco, V; Hassan, Cesare; Winn, S; Stoppino, V; Faleo, D; Attili, Af |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile